Macrophages exert antitumorigenic activity through phagocytosis, but phagocytosis-enhancing therapeutics have not improved acute myeloid leukemia (AML) outcomes. To identify phagocytosis regulators, we performed CRISPR knockout screens in human AML cells …
Source link
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity | Science
